Synthesis and biological activities of Bis alkyl 1,3,4-oxadiazole incorporated azo dye derivatives  by Shridhar, A.H. et al.
Arabian Journal of Chemistry (2016) 9, S1643–S1648King Saud University
Arabian Journal of Chemistry
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLESynthesis and biological activities of Bis alkyl
1,3,4-oxadiazole incorporated azo dye derivatives* Corresponding author. Tel.: +91 (0)8282 256308 (O); fax: +91
(0)8282 256255.
E-mail address: jkeshavyya@gmail.com (J. Keshavayya).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.arabjc.2012.04.018
1878-5352 ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).A.H. Shridhar a, J. Keshavayya a,*, S.K. Peethambar b, H. Joy Hoskeri ca Department of Studies and Research in Chemistry, School of Chemical Sciences, Kuvempu University, Jnana
Sahyadri, Shankaraghatta 577 451, Karnataka, India
b Department of Biochemistry, Kuvempu University, Jnana Sahyadri, Shankaraghatta 577 451, Karnataka, India
c Department of Studies and Research in Biotechnology, School of Bio-Sciences, Kuvempu University, Jnana Sahyadri,
Shankaraghatta 577 451, Karnataka, IndiaReceived 16 November 2011; accepted 23 April 2012
Available online 2 May 2012KEYWORDS
Bis(alkyl-1,3,4-oxadiaz-
ole)azo dye;
8-Hydroxy quinoline;
Anti-microbial activity;
In vitro antioxidant activityAbstract 3,5-Bis(alkyl-1,3,4-oxadiazole-2-yl azo dyes were synthesized by a multi-step reaction
sequence. Structures of newly synthesized compounds were characterized and conﬁrmed by IR,
NMR, and Mass spectral studies. The synthesized compounds were screened for their antimicrobial
and in vitro antioxidant properties. The results of this investigation revealed that the newly synthe-
sized compounds are potent antibacterial and antioxidant agents. All the synthesized compounds
exhibit signiﬁcant biological activity and certainly hold a greater promise for discovering potent
biologically active molecules.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
In recent years, fungal and bacterial infections have become an
important complication and a major cause of morbidity and
mortality. The growing incidence of fungal and bacterial resis-
tance to existing antibiotics poses a serious medical problem in
treating pathogenic infections. Several ﬁve-membered hetero
cyclic drugs possess diverse biological effects. Nitrogen andoxygen containing ﬁve membered azoles are important bioac-
tive agents, due to their vast pharmacological and industrial
applications. Synthesis of such heterocyclic compounds is of
pharmaceutical importance and a foremost task for chemists.
1,3,4-Oxadiazole derivatives are heterocyclic compounds
which exhibit remarkable pharmacological activities. It has
been known that the activity of azo linkage increases with
the incorporation of a suitable heterocyclic moiety. Heterocy-
clic azo compounds are well known for their medicinal impor-
tance and are recognized for their use as antineoplastics (Child
et al., 1977), antidiabetics (Garg and Praksh, 1972), antiseptics
(Browing et al., 1926), anti-inﬂammatory, antibacterial (Khedr
et al., 2011; Nikhil et al., 2011) and other useful chemothera-
peutic agents (Bae et al., 2003; Sanjay et al., 2007). Azo dyes
are used as hypnotic drugs for the nervous system, in detecting
cancer as chemotherapeutic agents and are involved in the
structure of nucleic acids in living cells (Zeynel et al., 2008).
S1644 A.H. Shridhar et al.Azo dyes are known to be involved in a number of biological
reactions such as inhibition of DNA, RNA, protein synthesis,
carcinogenesis and nitrogen ﬁxation (Browing et al., 1926;
Rajendra et al., 1998). Evans blue and Congo red are being
studied as HIV inhibitors. This effect is believed to be caused
by binding of azo dyes to both protease and reverse transcrip-
tase of this dreadful virus (Fatma and Eser, 2007). 1,2,3-Oxa-
diazoles can also act as HIV integrase inhibitors (Sicardi et al.,
1980).
1,3,4-Oxadiazoles are ﬁve membered heterocyclic com-
pounds having signiﬁcant position in synthetic and medicinal
chemistries due to their wide array of biological activities such
as anti fungal (Parkash et al., 2010) antimicrobial (Sridhara et
al., 2010), anti-inﬂammatory, analgesic (Akhter et al., 2009;
Idrees et al., 2009; Tozcoparan et al., 2000), hypolipidemic
(Jayashankar et al., 2009) anti tubercular (Kumar et al.,
2010; Kucukguzel et al., 2002), anti-convulsant (Singh and
Pankaj, 2010; Bhat et al., 2010), and cytotoxic agents (Padm-
avathi et al., 2009), also as prostaglandin receptor antagonists
(George et al., 2000) and anti oxidant agent (Abdu Musad
et al., 2011; Bondock et al., 2009).
In view of the above mentioned ﬁndings and our previous
ﬁndings on synthesis and pharmacological activities of hetero-
cyclic compounds (Keshavayya et al., 2011a,b, 2006, 2007), in
the present study we made an efﬁcient attempt to synthesize al-
kyl bis 1,3,4-oxadiazole substituted azo dyes coupled with quin-
oline, possessing potent biological activities. Structures of the
synthesized compounds were conﬁrmed by 1H NMR, IR and
Mass spectral studies. Synthesized compounds were screened
for their antimicrobial and in vitro antioxidant properties.
2. Results and discussion
As depicted in Scheme 1, 1,3,4-oxadiazole azo dye derivatives
were synthesized by a multi-step reaction sequence. 1,3,4-Oxa-
diazoles were prepared by reacting 5-nitro bis iso-phthalic
dihydrazide with appropriate long chain fatty acids in the pres-
ence of phosphorous oxychloride gives 5-nitro alkyl bis 1,3,4-
oxadiazoles in good yields. 5-Nitro alkyl bis 1,3,4-oxadiazoles
were allowed to react with Zn/HCl using ethanol as a solvent
to convert the nitro group to amine. The newly synthesized
amine group was diazotized and coupled with 8-hydroxy quin-
oline to obtain bis alkyl 1,3,4-oxadiazole substituted azo dye 4OO
N+O- O
NH NH NH2NH2 O
NN
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R
i , ii
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1
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Scheme(a–f). The synthesized compounds were recrystallized using
methanol. The purity of the compounds was checked by
TLC. The structures of the newly synthesized compounds were
characterized by 1H NMR, IR and Mass spectra studies. The
synthesized compounds were found in good agreement with
the spectral data. The elemental analysis results were matched
within ±0.4% of the theoretical values.
The IR spectra of 1 showed an absorption peak at 3336.4 cm
1 due to hydrazide, a peak at 1507.1 cm1 due to NO2 and a
peak at 1633.3 cm1 due to C‚O absorption. These spectral
data of synthesized 5-nitro, iso-phthalic dihydrazide stand in
good agreement with those reported in the literature (Palekar
et al., 2009). The IR spectrum of the compound 2 showed
absorption peak at 1561.4 cm1 due to C‚N stretching vibra-
tion. The absence of C‚O peak at 1633.3 cm1 and NHNH2 at
3336.4 cm1 conﬁrms the formation of oxadiazoles. The 1H
NMR spectrum revealed a singlet at d 13–16 due to AOH pro-
tons, d 2–3 due to long chain aliphatic protons and d 6–8 due to
aromatic proton. The IR spectrum of compounds 4 a–f show-
ing an absorption peak at 3300–3400 cm1, was attributed to
AOH, at 1600–1700 cm1, due to N‚N, absorption at 1500–
1600 and C‚N at 2921 (aliphatic chain). The IR, 1H NMR
and mass spectral data were found in good agreement with
the newly synthesized compounds.
3. Pharmacology
Azoles exert antifungal activity through inhibition based on
the structure of the active site of oxadiazoles and extensive
investigation of the structure–activity relationships (SAR) of
azole has revealed that the oxadiazole ring, having oxygen,
nitrogen and the hydroxyl group was the pharmacophore of
antifungal agents [41].
3.1. Evaluation of minimal inhibitory concentrations (MICs)
Evaluation of MIC values of all the compounds 4a–f was car-
ried out using concentrations ranging from 2.5 to 20 mg/mL.
Compound 4c showed signiﬁcant inhibition at 2.5 mg/mL
against Pseudomonas aureginosa, Escherichia coli, and Candida
parapsilosis. While, compounds 4a and 4d showed maximum
inhibitory activity against P. aureginosa and C. parapsilosis
at MIC 2.5 mg/mL, lowest MIC was shown by compoundN
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Table 1 In vitro minimum inhibition concentration evaluation
of test compounds against Staphylococcus aureus, Pseudomonas
aureginosa, Bacillus subtilis, Escherichia coli, Candida albicans
and Candida parapsilosis.
5a4 5b2 5c1 5d3 5e5 5f6
Staphylococcus aureus 20 10 05 10 20 20
Pseudomonas aureginosa 10 05 05 10 10 10
Bacillus subtilis 10 10 2.5 05 20 20
Escherichia coli 10 05 2.5 05 10 –
Candida albicans 05 2.5 2.5 05 10 20
Candida parapsilosis – 05 05 10 10 –
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Figure 1 DPPH radical scavenging activity.
Synthesis and biological activities of Bis alkyl 1,3,4-oxadiazole incorporated azo dye derivatives S16454c. Compounds 4b, 4c and 4d demonstrated efﬁcient MIC
when compared to other test compounds. Results of MIC
are depicted in Table 1.
3.2. Antimicrobial screening
All synthesized compounds having heterocyclic system con-
taining bridgehead nitrogen and oxygen atoms possess en-
hanced antimicrobial activity. Among the synthesized
compounds 4c having moderate aliphatic chain length showed
signiﬁcant results in inhibitingStaphylococcus aureus andBacil-
lus subtilis growth with 21.83 ± 0.88 mm and
24.33 ± 1.01 mm zones of inhibition respectively when com-
pared to other compounds. Compounds 4b and 4a against P.
aureginosa produced 21.01 ± 0.56 mm and 17.69 ± 0.33 mm
zones of inhibition respectively; this was comparable to the ef-
fect of the standard used. Whereas compound 4d was signiﬁ-
cant and showed 17.5 ± 1.2 mm. Test compounds other than
4c showed moderate effect when compared to the standard
drug ampicillin against E. coli. Compound 4c showed signiﬁ-
cant inhibition against Candida albicans and C. parapsilosis
with 25.67 ± 0.58 mm and 17.33 ± 1.01 mm zones of inhibi-
tion respectively when compared to other compounds but less
efﬁcient than the standard drug ﬂuconazole. Evaluation of
antimicrobial activity revealed that the all the synthesized com-
pounds were effective in inhibiting the bacterial and fungal
growth but with some exceptions. Among all the compounds
tested, compounds 4b, 4d, and 4a showed signiﬁcant antimi-
crobial activity when compared to other compounds. Speciﬁ-
cally, compound 4c was more efﬁcient than otherTable 2 Antimicrobial activity of the synthesized compounds (4a–f)
subtilis, Escherichia coli, Candida albicans and Candida parapsilosis.
Compounds Zone of inhibition (mm)
Staphylococcus aureus Bacillus subtilis Escherichia coli
ATCC 25923 ATCC 6633 ATCC 25922
4a 10.33 ± 1.12 16.67 ± 0.95 17.88 ± 1.53
4b 17 ± 1.53 17.67 ± 0.88 18.83 ± 1.4
4c 21.83 ± 0.88 24.33 ± 1.01 23 ± 0.33
4d 17.33 ± 0.67 18.83 ± 0.33 18.33 ± 0.88
4e 12.28 ± 0.88 11.67 ± 0.33 17.17 ± 1.45
4f 10.33 ± 0.67 9.67 ± 1.01 13.67 ± 0.95
Ampicillin 17 ± 1.53 20.67 ± 0.33 14.33 ± 1.45
Fluconazole – – –
The value of each constituents consisted of ± S.E.M. of 03 replicates. Ncompounds but less potent than standard drug ampicillin. Re-
sults of in vitro antimicrobial activity are depicted in Table 2.
3.3. In vitro antioxidant screening
The free radical scavenging activity of test samples 4a–f was
measured by DPPH method according to Brand-Williams
et al. All the synthesized compounds having electron donating
groups like oxygen and nitrogen, exhibited free radical scav-
enging capacity in comparison with the standard Butylated
Hydroxytoulene (BHT). DPPH assay was carried out for com-
pounds 4a–f at different concentrations from 50 to 100 lM
concentration. Among the tested compounds, 4b and 4c
showed signiﬁcant DPPH scavenging activity (>70%) at con-
centration 100 lMwhereas other test compounds were less po-
tent than the standard BHT (Fig. 1). The variation exhibited in
DPPH scavenging capacity could be attributed to the effect of
different substitutions and results are presented in Table 3.
4. Experimental
All analytical grade chemicals were used directly. Melting
point of the synthesized compounds was determined in a scien-
tiﬁc melting point apparatus and uncorrected. The progress of
reaction was monitored by TLC using silica gel coated plates
(0.5 mm thickness, Merck) and spots were visualized under
UV radiation. Synthesized compounds were recrystallized
using suitable solvent system. Infra-red spectra were recorded
on a Perkin Elmer-spectrum RX-1model spectrophotometer
using KBr pellets. NMR spectra were recorded by a Bruker
DRX 400 MHz spectrometer and acquired on a Bruker
Avance-2 model spectrophotometer using DMSO as a solventagainst Staphylococcus aureus, Pseudomonas aureginosa, Bacillus
Pseudomonas aeruginosa Candida albicans Candida parapsilosis
ATCC 27853 ATCC 10231 ATCC 90018
17.69 ± 0.33 19.13 ± 0.33 ND
21.01 ± 0.56 22.33 ± 0.67 18.01 ± 0.33
20 ± 0.33 25.67 ± 0.58 17.33 ± 1.01
17.5 ± 1.2 18.98 ± 1.17 16.98 ± 1.13
15.11 ± 0.33 16.33 ± 1.86 15.17 ± 1.52
ND 11.33 ± 1.2 ND
19.67 ± 0.88 – –
– 19.3 ± 0.33 18.83 ± 1.13
D – Not Deﬁned.
Table 3 DPPH radical scavenging activity of compound 4a–f.
Concentration in lM 4a 4b 4c 4d 4e 4f BHT
50 40.17 43.11 49.16 42.13 34.24 26.33 75.13
100 51.19 69.89 73.67 59.13 49.33 46.03 90.02
S1646 A.H. Shridhar et al.and TMS as an internal reference. The crude compounds were
puriﬁed by recrystallization method.
4.1. Synthesis of aryl 3-nitro iso-phthalic acid dihydrazide (1)
The 3-nitro iso-phthalic acid dihydrazide (1) was synthesized
by adopting reported method. Hydrazine hydrate (0.2 mmol)
was added drop-wise to the solution of iso-phthalic ester
(0.1 mmol) in 30 mL of dried ethanol with vigorous stirring.
The resulting mixture was reﬂuxed for 4–6 h. The progress of
the reaction was monitored by TLC with the solvent system
petroleum ether: ethyl acetate (1:1) as the mobile phase and
visualized under UV light. The excess ethanol was distilled
out and the contents were cooled at room temperature. The
yellow solid mass formed was ﬁltered and washed thoroughly
using brine solution and the resultant was dried.
4.2. General procedure for the synthesis of 2, 20-(5-nitrobenzene-
1, 3-diyl) bis (5-alkyl-1,3,4-oxadiazole) (2)
A suspension of 5-nitrobenzene-1,3-dicarbohydrazide
(1 mmol) and the appropriate long chain fatty acids (2 mmol)
in POCl3 (10 ml) were reﬂuxed for 6–8 h. The progress of the
reaction was monitored on TLC by using silica gel plates using
petroleum ether and ethyl acetate (7:3) as the eluting system
and visualized in UV light. The reaction mixture was allowed
to cool to room temperature and slowly poured over crushed
ice kept overnight. The solid thus, separated out was neutral-
ized with anhydrous sodium bicarbonate, ﬁltered, washed with
water and recrystallized using ethanol.
4.3. General procedure for the synthesis of 3,5-bis(alkyl-1,3,4-
oxadiazol-2-yl)aniline
A suspension of nitro compound (1 mmol) and SnCl22H2O
(5 mmol) was dissolved in 0.02 M methanolic HCl solution
and reﬂuxed for 3–4 h at 70–80 C under nitrogen atmosphere.
The reaction mixture was concentrated under reduced pres-
sure, diluted with ethyl acetate, and washed with aq. NaHCO3
and water. The organic layer was dried over anhydrous sodium
sulphate, concentrated, and then recrystallized from methanol.
4.4. General procedure for the synthesis of 3,5-bis(alkyl-1,3,4-
oxadiazol-2-yl azo dye (4a–f)
The newly synthesized amine (1 mmol) was taken in HCl and
cooled to 0–5 C, NaNO2 dissolved in a suitable solvent
(1.25 mmol) was added dropwise with constant stirring with-
out allowing the temperature to rise above 10 C to get a dia-
zonium salt. After complete addition the reaction mixture was
adjusted to pH 5–6, the coupling compound (1 mmol) was dis-
solved in a suitable solvent and cooled to 0–5 C and this solu-
tion was added to the above mixture gradually withoutallowing the temperature rise above 0–5 C. After complete
addition, the reaction mixture was stirred for 1–2 h for the
completion of reaction. The dye obtained was ﬁltered and
thoroughly washed with water, dried and recrystallized using
methanol that afforded a red coloured dye, a red colour solid
with 83% yield, m.p. 168–169 C.
4.5. Spectral data of synthesized compound
4.5.1. 3,5-Bis (alkyl-1,3,4-oxadiazol-2-yl azo dye (4a)
This dye was isolated as red colour solid with 83% yield, m.p.
168–169 C; IR (Vmax, cm1) = 2849 (CAH), 1630 (C‚N),
1507 (NO2), 2921 (aliphatic chain),
1H NMR (CDCl3) (d
ppm) = 0.92 (t, 6H, aliphatic CH3), 1.27 (Br, S, 12H, CH2),
1.33 (m, 4H, Ar–H), 1.6 (t, 4H, CH2) 2.54 (m, 4H, CH2),
8.76 (d, 1H, Ar–H), 8.07 (d, 2H, Ar–H), 7.95 (d, 1H, Ar–H),
7.92 (s, 1H, Ar–H), 7.83 (d, 1H, Ar–H), 7.32 (d, 1H, Ar–H),
7.18 (t, 1H, Ar–H), 14.63 (s, 1H, OH) .MS m/z 582.27
(M+) 13C NMR (CDCl3) (d ppm) = 14.6, 23.1, 26.0–32.4 (ali-
phatic-C), 118.6, 118.3, 121.3, 123.8, 127.4, 131.4, 134.6, 134.5,
137.8, 143.1, 150.6, 150.8, 153.2. (Ar–C), 162.6 (C5 of oxadiaz-
ole), 168.8 (C2 of oxadiazole). Anal. Calcd. For C33H39N7O3;
C, 68.14; H, 6.76; N, 16.86. Found; C, 68.23; H, 6.59; N, 16.91.
4.5.2. 3,5-Bis (alkyl-1,3,4-oxadiazol-2-yl azo dye (4b)
This dye was isolated as red colour solid with 78% yield, m.p.
175–176 C; IR (Vmax, cm1) = 2849 (CAH), 1630 (C‚N),
1507 (NO2), 2921 (aliphatic chain),
1H NMR (CDCl3) (d
ppm) = 0.94 (t, 6H, aliphatic CH3), 1.29 (m, 20H, CH2) 1.34
(m, 4H, CH2) 1.63 (m, 4H, CH2), 2.59 (t, 4H, CH2) 8.76 (d,
1H, Ar–H), 8.12 (d, 2H, Ar–H), 7.97 (d, 1H, Ar–H), 7.93 (s,
1H, Ar–H), 7.82 (d, 1H, ArH), 7.31 (d, 1H, Ar–H), 7.15 (t,
1H, Ar–H). 14.7 (s, 1H, OH) .MS m/z= 638.46 (M+) 13C
NMR (CDCl3) (d ppm) = 14.8, 23.3, 26.0–32.6 (aliphatic-C),
118.4, 118.7, 121.7, 123.5, 127.1, 131.8, 133.2, 134.3, 138.2,
143.7, 150.2, 151.3, 153.7. (Ar–C), 162.2 (C5 of oxadiazole),
169.2 (C2 of oxadiazole). Anal. Calcd. For C37H47N7O3; C,
69.67; H, 7.43; N, 15.37. Found; C, 68.92; H, 7.53; N, 15.58.
4.5.3. 3,5-Bis (alkyl-1,3,4-oxadiazol-2-yl azo dye (4c)
IR (Vmax, cm1) = 2849 (CAH), 1630 (C‚N), 1507 (NO2),
2921 (aliphatic chain) 1H NMR (CDCl3) (d ppm) = 15.2 (s,
1H), 0.95 (t, 6H, aliphatic CH3), 1.26 (m, 28H, CH2) 1.31
(m, 4H, CH2) 1.64 (m, 4H, CH2), 2.58 (t, 4H, CH2) 8.79 (d,
1H, Ar–H), 8.11 (d, 2H, Ar–H), 7.95 (d, 1H, Ar–H), 7.90 (s,
1H, Ar–H), 7.85 (d, 1H, Ar–H), 7.29 (d, 1H, Ar–H), 7.18 (t,
1H, Ar–H). 24.7 (s, 1H, OH). 13C NMR (CDCl3) (d
ppm) = 14.3, 23.2, 29.8, 30.0, 30.2, 32.2, 32.5 (aliphatic-C),
118.6, 118.4, 121.3, 123.6, 127.7, 131.4, 134.5, 135.3, 137.3,
143.4, 150.7, 150.4, 153.7. (Ar–C), 162.4 (C5 of oxadiazole),
169.1 (C2 of oxadiazole). MS m/z= 694.17(M+). Anal. Calcd.
For C41H55N7O3; C, 70.96; H, 7.99; N, 14.13. Found; C, 69.98;
H, 7.74; N, 16.15.
Synthesis and biological activities of Bis alkyl 1,3,4-oxadiazole incorporated azo dye derivatives S16474.5.4. 3,5-Bis (alkyl-1,3,4-oxadiazol-2-yl azo dye (4d)
This dye was isolated as red colour solid with 86% yield, m.p.
188–189 C; IR (Vmax, cm1) = 2849 (CAH), 1630 (C‚N),
1507 (NO2), 2921 (aliphatic chain)
1H NMR (CDCl3) (d
ppm) = 15.4 (s, 1H), 0.97 (t, 6H, aliphatic CH3), 1.28 (m,
36H, CH2) 1.33 (m, 4H, CH2) 1.624 (m, 4H, CH2), 2.56 (t,
4H, CH2) 8.72 (d, 1H, Ar–H), 8.32 (d, 2H, Ar–H), 7.98 (d,
1H, Ar–H), 7.91 (s, 1H, Ar–H), 7.82 (d, 1H, Ar–H), 7.27 (d,
1H, Ar–H), 7.14 (t, 1H, Ar–H). MS m/z= 751.23 (M+) Anal.
Calcd. For C45H63N7O3; C, 72.06; H, 8.47; N, 13.307. Found;
C, 71.52; H, 7.98; N, 14.16.
4.5.5. 3,5-Bis (alkyl-1,3,4-oxadiazol-2-yl azo dye (4e)
This dye was isolated as red colour solid with 77% yield, m.p.
192–193 C; IR (Vmax, cm1) = 2849 (CAH), 1630 (C‚N),
1507 (NO2), 2921 (aliphatic chain)
1H NMR (CDCl3) (d
ppm) = 15.8 (s, 1H), 0.93 (t, 6H, aliphatic CH3), 1.24 (m,
44H, CH2) 1.36 (m, 4H, CH2) 1.63 (m, 4H, CH2), 2.58 (t,
4H, CH2) 8.76 (d, 1H, Ar–H), 8.34 (d, 2H, Ar–H), 7.93 (d,
1H, Ar–H), 7.96 (s, 1H, Ar–H), 7.84 (d, 1H, Ar–H), 7.29 (d,
1H, Ar–H), 7.16 (t, 1H, Ar–H). MS m/z= 806.35 (M+) Anal.
Calcd. For C49H71N7O3; C, 73.01; H, 8.88; N, 12.16. Found;
C, 74.19; H, 8.62; N, 15.89.
4.5.6. 3,5-Bis (alkyl-1,3,4-oxadiazol-2-yl azo dye (4f)
This dye was isolated as red colour solid with 84% yield, m.p.
198–199 C; IR (Vmax, cm1) = 2849 (CAH), 1630 (C‚N),
1507 (NO2), 2921 (aliphatic chain)
1H NMR (CDCl3) (d
ppm) = 14.3 (s, 1H), 0.98 (t, 6H, aliphatic CH3), 1.25 (m,
52H, CH2) 1.36 (m, 4H, CH2) 1.68 (m, 4H, CH2), 2.52 (t,
4H, CH2) 8.79 (d, 1H, Ar–H), 8.38 (d, 2H, Ar–H), 7.96 (d,
1H, Ar–H), 7.92 (s, 1H, Ar–H), 7.87 (d, 1H, Ar–H), 7.31 (d,
1H, Ar–H), 7.12 (t, 1H, Ar–H).n MS m/z= 862.97 (M+)
Anal. Calcd. For C53H79N7O3; C, 73.83; H, 9.32; N, 11.37.
Found; C, 73.62; H, 9.52; N, 11.85.
4.6. Determination of minimal inhibitory concentrations (MIC)
The agar dilution susceptibility test was performed based on
the modiﬁed method of NCCLS, 2003 and CLSI, 2009 to
determine the MIC of the synthesized compounds. The test
compounds (4a–g) dissolved in sterilized 5% DMSO
(400 mg/mL concentration) were taken as standard stock. A
series of two fold dilutions of each compound in the ﬁnal con-
centrations of 40, 20, 10, 5, and 2.5 mg/mL were prepared in
nutrient agar for bacteria and potato dextrose agar for fungi.
After solidiﬁcation, the plates were spotted with 100 lL of
overnight grown bacterial cultures approximately containing
1 · 104 CFU/mL. The test was carried out in triplicates. The
plates of bacterial culture were incubated at 37 C for 18–
24 h and fungal cultures were incubated at 24 C for 24–
48 h. After incubation, the MIC was determined.
4.7. Antimicrobial activity
The antimicrobial activity of newly synthesized compounds
4a–f was determined by well plate method in nutrient agar
(antibacterial activity) (Lehrer et al., 1991) and Sabouraud
dextrose agar (antifungal activity). The in vitro antibacterial
activity was carried out against 24 h old cultures of bacterial
strains and 72 h old cultures of fungal strains. In this work,E. coli, S. aureus, B. subtilis, Salmonella typhi, were used to
investigate the antibacterial activities and Pseudomonas Aeru-
ginosa, C. albicans, C. parapsilosis, were used to investigate
the antifungal activities.
The test compounds were dissolved in dimethyl sulphoxide
(DMSO) at concentration of 100 and 50 mg/mL. Approxi-
mately 1 cm3 of a 24 h broth culture was placed in sterile petri
dishes. Molten nutrient agar kept at 45 Cwas then poured into
the Petri dishes and allowed to solidify. Six millimetre diameter
holes were then punched carefully using a sterile cork borer and
completely ﬁlled with the test solutions. The plates were incu-
bated for 24 h at 37 C. The inhibition zone was observed and
documented after 24 h for bacterial culture and 72 h for fungal
cultures. The clear zone around the holes in each plate was mea-
sured as zone of inhibition in mm. Experiments were triplicates
and standard deviation was calculated. The zone of inhibition
of antifungal activity was determined after 72 h culture. The
results were compared with Fluconazole.
4.8. In vitro antioxidant screening
The free radical scavenging activity of synthesized 4a–g was
measured by DPPH (2,2-diphenyl 1-picrylhydrazyl) using the
method proposed by Brand-Williams et al. (1995). The reac-
tion mixture of the synthesized compounds viz. 4a–g at differ-
ent concentrations ranging from 25 to 100 lg aliquots was
taken and the volume was made up to 3 mL by using metha-
nol, to this 1 mL of 0.1 mM solution of DPPH in methanol
was added and kept in the dark for 30 min at room tempera-
ture, O.D was measured at 517 nm and the inhibition concen-
tration was calculated using the formula given below. 3 mL of
methanol and 1 mL of DPPH were used as controls.
% of inhibition = [(A–A1)/A] · 100.
A= the absorbance of the control at 517 nm,
A1 = the absorbance of the compound 4a–g at 517 nm.
5. Conclusion
This investigation proposes a convenient, economical, cheaper
and useful method for the synthesis of 3,5-bis(alkyl-1,3,4-oxa-
diazol-2-yl) azo dyes, coupled with quinoline, which are bio-
logically active molecules possessing antimicrobial and
in vitro antioxidant properties. These new classes of heterocy-
cles, exhibit a signiﬁcant antimicrobial and antioxidant activi-
ties. 1,3,4-Oxodiazole azo dye coupled with 8-hydroxy
quinoline showed active antioxidant capacity than 1,3,4-oxo-
diazole azo dye coupled with naphthols. The preliminary anti-
microbial activity studies revealed that the azo dye having
1,3,4-oxodiazole moiety exhibited a potential antimicrobial
activity. Hence, it can be concluded that, this new class of
compounds certainly holds a greater promise in discovering
a potent antimicrobial and antioxidant agent.Acknowledgements
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